Key Statistics for Prostate Cancer

Prostate cancer is the most prevalent cancer in men across the globe. About 1.4 million new U.S. cases were recorded in the year 2020.

Notably, the cases do not spread uniformly across all communities. Some demographics record a higher or lower incidence due to several other factors. As a result, different continents have differing levels of incidence rates.

Moreover, the incidence of prostate cancer rises alarmingly in men older than 65, and most cases are diagnosed after 50 years of age.

And so these statistics are more crucial now than ever—because it allows you to take preventive steps to keep your prostate healthy.

Global Incidence: Prostate cancer is the most common cancer in men throughout the world. In 2020, over 1.4 million new cases were reported globally. Age-standardized incidence rate (ASIR): 30.7 per million men Incidence rates are higher in regions such as Northern America, Europe, and Oceania with over 59 cases/100,000 males.

Image Credit: Frontiers

Regional Variations: The incidence rates differ greatly for various regions. Prostate cancer accounts for more cases diagnosed in Europe and Northern America than in Asia or Africa. Ireland, for instance, has an ASIR of 110.7 among males to Bhutan which reports as low a rate as 0.9 per​100,000 in males​.

Age-Specific Incidence: Prostate cancer incidence increases with age. The disease is uncommon in men under 40. It is more common in those over the age of 50. Occurrence peaks in those aged 65 and older​​.

Global Mortality Statistics: As for millions of American men living across the country with prostate cancer, the rate of the prostate cancer death is comparatively low. The global ASMR for men was 7.7 in 100,000 in 2020. In the US 19 in 100,000 men die of prostate cancer annually.

Trends Over Time: Incidence of prostate cancer will only increase. Despite this, prostate cancer mortality rates continue to be unchanged across the regions. Rates in some cases go down, due to better methods of finding those tumors and through more effective treatment.

Comparison with Other Cancers: Prostate cancer is the second leading cause of cancer death in men. The first leading cause is lung cancer. In comparison to other cancers, men have a high survival rate of prostate cancer. The chances are better than surviving pancreatic or lung cancer for instance​.

Age Distribution: Prostate cancer risk rises with age. So it’s typical to find more men with prostate over the age of 65. That doesn’t mean younger people cannot have this type of malignancy either. It’s, however, rare in men under 40 years old.

Image Credit: Channels TV

Racial and Ethnic Disparities: Prostate cancer incidence rates have strong links to what race a person is. Concrete data shows that the death rate is higher in African-American men than in any other racial group.

Genetic Predisposition: Family history is also a huge factor. If a man’s father or brother experienced prostate cancer (first-degree relative), then there is a high chance that he may also experience it.

Percentage of Cases by Stage: In managing prostate cancer successfully, there’s no better strategy than detecting it early. About 69% of prostate cancer cases are diagnosed at a local stage when there is an opportunity for the best prognosis and survival. On the flip side, just 8 percent of cases are discovered at a late distant stage when cancer has already spread​.

Trends in Early Detection The introduction of cancer screening programs has driven more early-stage diagnoses, specifically with the Prostate-Specific Antigen (PSA) test. Contributing to this trend with the high rates of early detection has supported higher survival and treatment outcomes.

Survival Rates Overall: the survival rate for prostate cancer is quite high relative to other cancers. In all stages combined, the 5-year relative survival rate is about 97.5%
Stage-Specific Survival Rates: The Survival rate of prostate cancer varies significantly by stage at diagnosis:

Whether a person survives prostate cancer depends on the stage of the tumor at diagnosis, age, and overall health.

Prevalence of Different Treatment Modalities: There are quite a few treatment options if you have prostate cancer. Typical treatment options include:

Treatment is driven by patient preference and the potential side effects of treatment versus cure rates.

Success Rates of Various Treatments: Many prostate cancers are not destined to be lethal. This means most men will ultimately die from other causes regardless of whether they develop such a tumor. The 5-year survival rate for localized prostate cancer is nearly 100%. The advancement of treatments and the use of combinatorial therapies are steadily enhancing outcomes for those patients with more high-risk variants.

Healthcare Costs Associated with Prostate Cancer: You may incur hefty healthcare costs when treating prostate cancer, including those associated with surgery (where the tumor is removed), radiation therapy, hormone therapy, and continued observation. Prostate cancer is the single most expensive disease in men in the United States, currently costing billions of dollars per year just to treat it alone​.

Image credit: Nature Careers

Lost Productivity Due to Illness and Treatment: Productivity due to illness and treatment The economic consequences go beyond the prevalent medical costs. Additionally, patients experience lost productivity from illness and side effects of treatment. It includes time off work and loss of basic functionality which can be financially disastrous for the patient and their family.

PSA Screening Statistics: PSA screening has been a controversial yet valuable tool in detecting prostate cancer early. Some quarters think it is controversial because it is sensitive enough to discover prostate cancers earlier. Yet, oversensitivity can mean it also gives false results of tumors. This increases fears of overdiagnosis and overtreatment.

Impact of Screening on Mortality Rates: Studies have shown that regions that have PSA screening programs have much more reduced deaths due to prostate cancer.

Prostate cancer, the second most common malignancy in men and a significant public health problem continues to have important incidence and mortality rates globally among cancers. Knowing these prostate cancer statistics and facts can help those who look to prevent, detect early, or find effective treatments. You can make a difference by being informed and proactive.

For more detailed information, you can consult reliable sources. For instance, the International Agency for Research on Cancer and the National Cancer Institute.

1.Cancer of the Prostate - Cancer Stat Facts. (n.d.). SEER. 

2.Cancer today. (n.d.). 

3.Grant. (2024, March 11). GLOBOCAN 2022: Latest global cancer data shows rising incidence and stark inequities. UICC. 

4.Wang, L., Lu, B., He, M., Wang, Y., Wang, Z., & Du, L. (2022a). Prostate cancer incidence and mortality: Global status and temporal trends in 89 countries from 2000 to 2019. Frontiers in Public Health, 10.